Pegfilgrastim biosimilar (CuraTeQ Biologics)

培非格司亭生物类似药 (CuraTeQ Biologics)

Report date: 2026/04/22 20:01:10

Base Information

Drug NamePegfilgrastim biosimilar (CuraTeQ Biologics)
Drug Alias NamePeg-filgrastim biosimilarPegylated filgrastimPegylated granulocyte colony stimulating factorRecombinant pegfilgrastimDYRUPEG +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCuraTeQ Biologics Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCuraTeQ Biologics Pvt Ltd
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A